Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
BIMI International Medical Inc is a pharmaceutical retailers business based in the US. BIMI International Medical shares (BIMI) are listed on the NASDAQ and all prices are listed in US Dollars. BIMI International Medical employs 222 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$0.62|
|52-week range||$0.57 - $2.81|
|50-day moving average||$0.74|
|200-day moving average||$1.17|
|Wall St. target price||$12.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.50|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||1.92%|
|1 month (2021-09-16)||-12.44%|
|3 months (2021-07-16)||-43.99%|
|6 months (2021-04-15)||-57.99%|
|1 year (2020-10-15)||-68.44%|
|2 years (2019-10-15)||-89.32%|
|3 years (2018-10-15)||4.74|
|5 years (2016-10-14)||1.11|
|Revenue TTM||$20.1 million|
|Gross profit TTM||$2.5 million|
|Return on assets TTM||-4.52%|
|Return on equity TTM||-47.45%|
|Market capitalisation||$20.3 million|
TTM: trailing 12 months
There are currently 165,972 BIMI International Medical shares held short by investors – that's known as BIMI International Medical's "short interest". This figure is 381.6% up from 34,464 last month.
There are a few different ways that this level of interest in shorting BIMI International Medical shares can be evaluated.
BIMI International Medical's "short interest ratio" (SIR) is the quantity of BIMI International Medical shares currently shorted divided by the average quantity of BIMI International Medical shares traded daily (recently around 263447.61904762). BIMI International Medical's SIR currently stands at 0.63. In other words for every 100,000 BIMI International Medical shares traded daily on the market, roughly 630 shares are currently held short.
However BIMI International Medical's short interest can also be evaluated against the total number of BIMI International Medical shares, or, against the total number of tradable BIMI International Medical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case BIMI International Medical's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 BIMI International Medical shares in existence, roughly 10 shares are currently held short) or 0.0079% of the tradable shares (for every 100,000 tradable BIMI International Medical shares, roughly 8 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against BIMI International Medical.
Find out more about how you can short BIMI International Medical stock.
We're not expecting BIMI International Medical to pay a dividend over the next 12 months.
BIMI International Medical's shares were split on a 10:25 basis on 15 September 2010. So if you had owned 25 shares the day before before the split, the next day you'd have owned 10 shares. This wouldn't directly have changed the overall worth of your BIMI International Medical shares – just the quantity. However, indirectly, the new 150% higher share price could have impacted the market appetite for BIMI International Medical shares which in turn could have impacted BIMI International Medical's share price.
Over the last 12 months, BIMI International Medical's shares have ranged in value from as little as $0.57 up to $2.81. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BIMI International Medical's is -0.3524. This would suggest that BIMI International Medical's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, BIMI International Medical has bucked the trend.
BIMI International Medical Inc. , together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. It offers prescription and over-the-counter drugs, nutritional supplements, health foods, and sundry products, as well as traditional Chinese medicines, personal and family care products, and miscellaneous items under the Lijiantang Pharmacy brand name. The company also provides IT research and development services. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as BOQI International Medical Inc. and changed its name to BIMI International Medical Inc.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.